Chacko, Matthews <br/><br/>
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.  [electronic resource] 

 -  American heart journal  May 2006 
 - 1032.e1-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2006.02.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Anticoagulants--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Hemorrhage--chemically induced<br/>Heparin--therapeutic use<br/>Hirudins--adverse effects<br/>Humans<br/>Male<br/>Multicenter Studies as Topic<br/>Myocardial Infarction--etiology<br/>Myocardial Revascularization--statistics & numerical data<br/>Peptide Fragments--adverse effects<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins--adverse effects<br/>Retrospective Studies<br/>Risk Assessment<br/>Sex Factors